Stockscreener 앱 받기
21.39
2.00%
0.42
전일 마감가:
$20.97
열려 있는:
$21.31
하루 거래량:
1.53M
Relative Volume:
0.74
시가총액:
$1.45B
수익:
$796.00M
순이익/손실:
$-136.49M
주가수익비율:
-10.23
EPS:
-2.09
순현금흐름:
$-64.24M
1주 성능:
+2.25%
1개월 성능:
+18.44%
6개월 성능:
+2.25%
1년 성능:
-37.66%
1일 변동 폭
$20.56
$21.68
1주일 범위
$20.20
$22.09
52주 변동 폭
$9.98
$38.28
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
21.39 | 1.42B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 재개 | Stifel | Hold |
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Don't Buy Tandem Diabetes Care Until This Big Thing Happens - AOL.com
(TNDM) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
Tandem Diabetes Care (TNDM) Sees Target Price Raised by Citigrou - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry? - 富途牛牛
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now - TradingView
Did Tandem’s Insulin Pump Correction and Securities Probe Just Shift Tandem Diabetes Care's (TNDM) Investment Narrative? - Sahm
Tandem Diabetes Care Appoints Sandra Beaver to Board - MSN
How Tandem Diabetes Care Inc. stock valuations compare to rivalsTrade Entry Report & Free Daily Entry Point Trade Alerts - Newser
Is Tandem Diabetes Care Inc. (TD5A) stock resilient in recession scenariosJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Taking Stock of Tandem Diabetes Care (TNDM) Valuation After Fresh Analyst Upgrades and Reaffirmed Optimism - Sahm
DelveInsight expects the Artificial Pancreas Device Market to grow at a CAGR of 16.33% through 2032 - The Globe and Mail
Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know - Finviz
Will Tandem Diabetes Care Inc. (TD5A) stock outperform value peersTrade Analysis Report & Growth Oriented Trade Recommendations - Newser
Tandem Diabetes Care Stock Gains After Analyst Raises Target to $23News and Statistics - IndexBox
Why Tandem Diabetes Care Inc. (TD5A) stock could be top winnerM&A Rumor & Safe Entry Zone Identification - Newser
TNDM SEC FilingsTandem Diabetes 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Tandem Diabetes Care’s (TNDM) Valuation After Legal Probe and t:slim X2 Pump Correction Announcement - Yahoo Finance
TNDM: Morgan Stanley Raises Price Target Amidst Maintained Ratin - GuruFocus
How Tandem Diabetes Care Inc. (TD5A) stock reacts to Fed tightening2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
Free cash flow per share of Tandem Diabetes Care, Inc. – LSE:0M0F - TradingView
(TNDM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
How Recent Product Correction and Legal Inquiry May Impact Tandem Diabetes Care’s (TNDM) Investment Outlook - Sahm
Risk Check: What makes Tandem Diabetes Care Inc. (TD5A) stock appealing to growth investorsQuarterly Trade Summary & Weekly High Return Forecasts - moha.gov.vn
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
What risks investors should watch in Tandem Diabetes Care Inc. stockPortfolio Update Report & Verified Short-Term Plans - BỘ NỘI VỤ
A Fresh Look at Tandem Diabetes Care (TNDM) Valuation Following Insulin Pump Device Correction News - Sahm
[Form 4] TANDEM DIABETES CARE INC Insider Trading Activity - Stock Titan
[Form 3] TANDEM DIABETES CARE INC Initial Statement of Beneficial Ownership - Stock Titan
Implantable Insulin Pumps Market Size to Hit USD 14.27 Billion by 2034 - Precedence Research
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bakersfield.com
Tandem Diabetes Care Shows Market Leadership With Jump To 83 RS Rating - MSN
Why Tandem Diabetes Care (TNDM) Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next - Sahm
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Yahoo Finance
Tandem Diabetes Care, Inc.Common Stock (NQ: TNDM - Markets Financial Content
Momentum Stocks November 2025: Tandem Diabetes Sell, Vicor & Cardinal Health BuyNews and Statistics - IndexBox
Why Tandem Diabetes Care Inc. stock is trending among retail tradersTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Tandem Diabetes Care Inc. (TD5A) stock a momentum leaderLayoff News & Verified Momentum Stock Alerts - newser.com
Why millennials buy Tandem Diabetes Care Inc. (TD5A) stockJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
Barclays Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Can Tandem Diabetes Care Inc. stock deliver surprise earnings beatQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
(TNDM) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.28%
자본화:
|
볼륨(24시간):